9887 — Nanjing Leads Biolabs Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$9.62bn
- HK$9.45bn
Annual cashflow statement for Nanjing Leads Biolabs Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -362 | -301 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 128 | 86 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 18.1 | 70.3 |
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Cash from Operating Activities | -193 | -119 |
| Capital Expenditures | -11.7 | -2.98 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 147 | -64.3 |
| Change in Net Investments | ||
| Cash from Investing Activities | 135 | -67.3 |
| Financing Cash Flow Items | -6.87 | -6.94 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 49.5 | 309 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -5 | 125 |